378 related articles for article (PubMed ID: 26210742)
1. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
[TBL] [Abstract][Full Text] [Related]
2. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium.
Ghaleb AM; Aggarwal G; Bialkowska AB; Nandan MO; Yang VW
Mol Cancer Res; 2008 Dec; 6(12):1920-7. PubMed ID: 19074836
[TBL] [Abstract][Full Text] [Related]
3. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Krüppel-like factor 9 in human colorectal cancer.
Kang L; Lü B; Xu J; Hu H; Lai M
Pathol Int; 2008 Jun; 58(6):334-8. PubMed ID: 18477211
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.
Nandan MO; Ghaleb AM; McConnell BB; Patel NV; Robine S; Yang VW
Mol Cancer; 2010 Mar; 9():63. PubMed ID: 20298593
[TBL] [Abstract][Full Text] [Related]
7. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
9. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine.
McConnell BB; Bialkowska AB; Nandan MO; Ghaleb AM; Gordon FJ; Yang VW
Cancer Res; 2009 May; 69(10):4125-33. PubMed ID: 19435907
[TBL] [Abstract][Full Text] [Related]
12. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice.
Lo Sasso G; Bovenga F; Murzilli S; Salvatore L; Di Tullio G; Martelli N; D'Orazio A; Rainaldi S; Vacca M; Mangia A; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1497-507, 1507.e1-13. PubMed ID: 23419360
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.
Jiang L; Yang S; Yin H; Fan X; Wang S; Yao B; Pozzi A; Chen X; Harris RC; Zhang MZ
Mol Cancer Res; 2013 Sep; 11(9):1040-50. PubMed ID: 23741059
[TBL] [Abstract][Full Text] [Related]
16. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
[TBL] [Abstract][Full Text] [Related]
17. Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice.
Li Y; Teo WL; Low MJ; Meijer L; Sanderson I; Pettersson S; Greicius G
Oncogene; 2014 Jan; 33(3):369-77. PubMed ID: 23318418
[TBL] [Abstract][Full Text] [Related]
18. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
[TBL] [Abstract][Full Text] [Related]
19. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
[TBL] [Abstract][Full Text] [Related]
20. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
